Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (517)	11/23/2004 10:55:35 PM
From: Madharry	Read Replies (1) \| Respond to of 625

Any British barristers here? I wonder if someone could walk us through how something like this is handled in the british courts. How many years til final resolution?

To: Biomaven who wrote (517)	11/24/2004 7:22:36 AM
From: nigel bates	Read Replies (1) \| Respond to of 625

My instinct (and it's no more than that) is that at very least CATG will improve on 2%. Agreed on that, and they have at least a decent chance of going all they way to 5 / 6%. Won't be able to read the whole thing until the weekend, but fascinating stuff (if only for the history of MAb IP). Reminded me of why I started a law degree many years ago - and also why I dropped out after a year. <g> Would love to get to see the Abbott response.